5,0
30 nov 2024
Dipendente attuale, più di 3 anni
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Great culture, benefits, strong portfolio and nice people. Strong payer coverage for all products.
Svantaggi
Some growing pains, some favoritism, like most companies. Large geographical responsibilities. Chinese name in USA marketplace . Lack of contracting opportunities for small and mid size oncology providers.